Dr. Alexis Turgeon, MD
Claim this profileCHU de Québec - Université Laval
Studies Community-acquired Pneumonia
Studies Pneumonia
6 reported clinical trials
70 drugs studied
Affiliated Hospitals
Clinical Trials Alexis Turgeon, MD is currently running
Multiple Treatments
for Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Recruiting3 awards Phase 33 criteria
Heparin
for Community-Acquired Pneumonia
This trial is testing if higher doses of heparin, a blood thinner, can help patients hospitalized with pneumonia. These patients often have blood clot complications that worsen their condition. By preventing these clots, heparin might improve their recovery and reduce severe outcomes. Heparin has been shown to reduce the risk of blood clots in various patients, including those hospitalized for medical conditions and surgeries.
Recruiting2 awards Phase 35 criteria
More about Alexis Turgeon, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Alexis Turgeon, MD has experience with
- Interferon Beta-1a
- Heparin
- Ascorbic Acid
- Placebo
- ARBs
- Artesunate
Breakdown of trials Alexis Turgeon, MD has run
Community-acquired Pneumonia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexis Turgeon, MD specialize in?
Alexis Turgeon, MD focuses on Community-acquired Pneumonia and Pneumonia. In particular, much of their work with Community-acquired Pneumonia has involved treating patients, or patients who are undergoing treatment.
Is Alexis Turgeon, MD currently recruiting for clinical trials?
Yes, Alexis Turgeon, MD is currently recruiting for 3 clinical trials in Québec Quebec. If you're interested in participating, you should apply.
Are there any treatments that Alexis Turgeon, MD has studied deeply?
Yes, Alexis Turgeon, MD has studied treatments such as Interferon beta-1a, Heparin, Ascorbic Acid.
What is the best way to schedule an appointment with Alexis Turgeon, MD?
Apply for one of the trials that Alexis Turgeon, MD is conducting.
What is the office address of Alexis Turgeon, MD?
The office of Alexis Turgeon, MD is located at: CHU de Québec - Université Laval, Québec, Quebec G1J 1Z4 Canada. This is the address for their practice at the CHU de Québec - Université Laval.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.